Tag:
Mustek
Ghost Bites
Ghost Bites (AfroCentric | Aspen | Novus – Mustek)
Aspen announced the disposal of Aspen APAC and the market loved it. AfroCentric is disposing of Activo and the market forgot to notice - for now, at least. And for Novus, a purchase of 3,000 shares has turned out to be very expensive in the Mustek deal.
Ghost Bites
Ghost Bites (Mr Price | NEPI Rockcastle)
Mr Price isn't backing off on the NKD deal, despite the absolute hatred for the transaction from the market. NEPI's pre-close update shows the importance of looking at per-share growth.
Ghost Bites
Ghost Bites (Curro | Hulamin | Labat Africa | Sanlam)
The Curro deal gets the green light. Sanlam is doing important deals in India across the various Shriram investments. Labat Africa's numbers look very interesting. Hulamin's full year numbers are likely to be awful.
Ghost Bites
Ghost Bites (Accelerate Property Fund | Deneb | eMedia | Frontier Transport | Growthpoint | HCI | KAL | Life Healthcare | Nampak |...
A huge day of news saw the HCI stable (including Deneb, eMedia, Frontier Transport and Tsogo Sun) release results. Growthpoint released a quarterly update. Nampak is a great turnaround story, while Accelerate Property Fund is also coming right. Numbers came in from KAL, Life Healthcare and Novus as well, while Sirius Real Estate announced another acquisition.
Ghost Bites
Ghost Bites (Aspen | ASP Isotopes | Boxer | Calgro M3 | Canal+ and MultiChoice)
Boxer's underlying story is good, but the IPO ruined profit growth. Canal+ will inward list on the JSE after the MultiChoice deal. Calgro M3's earnings fell this period based on infrastructure timing. ASP Isotopes locked in their biggest ever supply deal. Aspen is thrilled that Mounjaro can be prescribed for obesity in SA.
DealMakers
Who’s doing what this week in the South African M&A space?
Weekly summary of Merger & Acquisition activity by South African companies
Ghost Bites
Ghost Bites (Investec | Mustek | Safari Investments)
Safari Investments had another strong period and is looking to raise capital for growth. Investec has guided for flat earnings in the six months to September 2025. Mustek's HEPS trajectory has finally turned positive, but what will they do next for growth?
Ghost Bites
Ghost Bites (Choppies | Metrofile | Momentum | Mustek | Orion Minerals | Supermarket Income REIT)
Momentum released excellent numbers, although they do have metrics that need work. Metrofile shareholders finally received an offer. Orion Minerals got the market excited with a funding package from Glencore. Mustek and Supermarket Income REIT are in the green, but not by much. Choppies is managing some growth in its core business.
